Share Price and Basic Stock Data
Last Updated: September 12, 2025, 12:39 pm
| PEG Ratio | 0.50 |
|---|
Quick Insight
Vaxtex Cotfab Ltd's current market dynamics present a mixed picture for investors. With a low Price-to-Earnings ratio of 20.0 and a Price-to-Book Value of 0.65x, the stock appears undervalued. However, the Return on Equity at 4.74% and Return on Capital Employed at 1.77% indicate low profitability and efficiency. The company's high debt level of 11.13Cr and negative reserves of -0.04Cr raise concerns about its financial health. Furthermore, a Cash Conversion Cycle of 971.94 days suggests potential liquidity issues. Investors should exercise caution and conduct further due diligence before considering an investment in Vaxtex Cotfab Ltd.
Competitors of Vaxtex Cotfab Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat Metallic Coal & Coke Ltd | 5.94 Cr. | 30.0 | / | 77.6 | 0.00 % | 0.37 % | 2.00 % | 100 | |
| Gensol Engineering Ltd | 177 Cr. | 46.0 | 896/31.9 | 1.72 | 155 | 0.00 % | 14.3 % | 22.4 % | 10.0 |
| Fusion Micro Finance Ltd | 2,513 Cr. | 186 | 307/124 | 101 | 0.00 % | 2.96 % | 54.5 % | 10.0 | |
| Five X Tradecom Ltd | 0.99 Cr. | 0.48 | / | 9.35 | 0.00 % | 0.00 % | 0.00 % | 10.0 | |
| East West Holdings Ltd | 63.4 Cr. | 4.97 | 8.90/4.82 | 5.12 | 0.00 % | 6.98 % | 0.86 % | 2.00 | |
| Industry Average | 7,087.83 Cr | 261.62 | 344.46 | 100.80 | 0.22% | 11.98% | 23.09% | 9.18 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 29.33 | 18.33 | 11.39 | 16.57 | 10.84 | 4.10 | 2.08 | -0.40 | 0.00 | 0.00 | 0.00 | 5.25 | 0.00 |
| Expenses | 28.86 | 17.91 | 12.82 | 16.43 | 10.30 | 3.93 | 10.72 | 0.82 | -0.09 | 0.11 | 0.37 | 5.34 | 0.21 |
| Operating Profit | 0.47 | 0.42 | -1.43 | 0.14 | 0.54 | 0.17 | -8.64 | -1.22 | 0.09 | -0.11 | -0.37 | -0.09 | -0.21 |
| OPM % | 1.60% | 2.29% | -12.55% | 0.84% | 4.98% | 4.15% | -415.38% | -1.71% | |||||
| Other Income | 0.64 | 0.11 | 1.57 | 0.16 | 0.05 | 0.01 | 0.02 | 0.44 | 0.02 | 0.03 | 0.01 | 1.06 | 0.46 |
| Interest | 0.28 | 0.36 | -0.02 | 0.00 | 0.02 | 0.02 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0.06 | 0.02 |
| Depreciation | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.00 | 0.00 | 0.01 | 0.01 | 0.06 | 0.01 | 0.01 |
| Profit before tax | 0.76 | 0.10 | 0.09 | 0.23 | 0.50 | 0.09 | -8.63 | -0.79 | 0.08 | -0.11 | -0.44 | 0.90 | 0.22 |
| Tax % | 0.00% | 0.00% | 0.00% | 13.04% | 26.00% | 22.22% | 0.00% | -18.99% | 0.00% | 0.00% | -11.36% | -47.78% | 0.00% |
| Net Profit | 0.77 | 0.10 | 0.09 | 0.21 | 0.37 | 0.07 | -8.63 | -0.65 | 0.08 | -0.12 | -0.39 | 1.32 | 0.22 |
| EPS in Rs | 0.05 | 0.01 | 0.01 | 0.01 | 0.02 | 0.00 | -0.47 | -0.04 | 0.00 | -0.01 | -0.02 | 0.07 | 0.01 |
Last Updated: August 20, 2025, 1:30 am
Below is a detailed analysis of the quarterly data for Vaxtex Cotfab Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5.25 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 5.25 Cr..
- For Expenses, as of Jun 2025, the value is 0.21 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 5.34 Cr. (Mar 2025) to 0.21 Cr., marking a decrease of 5.13 Cr..
- For Operating Profit, as of Jun 2025, the value is -0.21 Cr.. The value appears to be declining and may need further review. It has decreased from -0.09 Cr. (Mar 2025) to -0.21 Cr., marking a decrease of 0.12 Cr..
- For OPM %, as of Jun 2025, the value is 0.00%. The value appears strong and on an upward trend. It has increased from -1.71% (Mar 2025) to 0.00%, marking an increase of 1.71%.
- For Other Income, as of Jun 2025, the value is 0.46 Cr.. The value appears to be declining and may need further review. It has decreased from 1.06 Cr. (Mar 2025) to 0.46 Cr., marking a decrease of 0.60 Cr..
- For Interest, as of Jun 2025, the value is 0.02 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.06 Cr. (Mar 2025) to 0.02 Cr., marking a decrease of 0.04 Cr..
- For Depreciation, as of Jun 2025, the value is 0.01 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.01 Cr..
- For Profit before tax, as of Jun 2025, the value is 0.22 Cr.. The value appears to be declining and may need further review. It has decreased from 0.90 Cr. (Mar 2025) to 0.22 Cr., marking a decrease of 0.68 Cr..
- For Tax %, as of Jun 2025, the value is 0.00%. The value appears to be increasing, which may not be favorable. It has increased from -47.78% (Mar 2025) to 0.00%, marking an increase of 47.78%.
- For Net Profit, as of Jun 2025, the value is 0.22 Cr.. The value appears to be declining and may need further review. It has decreased from 1.32 Cr. (Mar 2025) to 0.22 Cr., marking a decrease of 1.10 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.01. The value appears to be declining and may need further review. It has decreased from 0.07 (Mar 2025) to 0.01, marking a decrease of 0.06.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: June 16, 2025, 3:31 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.63 | 4.43 | 18.45 | 21.97 | 27.76 | 26.15 | 61.91 | 75.62 | 16.62 | 5.25 |
| Expenses | 0.00 | 0.01 | 0.65 | 4.41 | 18.08 | 21.03 | 26.39 | 24.71 | 58.90 | 75.77 | 23.11 | 5.75 |
| Operating Profit | 0.00 | -0.01 | -0.02 | 0.02 | 0.37 | 0.94 | 1.37 | 1.44 | 3.01 | -0.15 | -6.49 | -0.50 |
| OPM % | -3.17% | 0.45% | 2.01% | 4.28% | 4.94% | 5.51% | 4.86% | -0.20% | -39.05% | -9.52% | ||
| Other Income | 0.00 | 0.01 | 0.03 | 0.03 | 0.00 | 0.05 | 0.02 | 0.06 | 0.38 | 2.22 | -2.12 | 1.13 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 1.06 | 1.09 | 1.08 | 0.63 | 0.07 | 0.11 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.01 | 0.10 | 0.11 | 0.14 | 0.15 | 0.30 | 0.28 | 0.15 | 0.10 |
| Profit before tax | 0.00 | 0.00 | 0.01 | 0.04 | 0.27 | 0.87 | 0.19 | 0.26 | 2.01 | 1.16 | -8.83 | 0.42 |
| Tax % | 0.00% | 50.00% | 37.04% | 31.03% | 52.63% | 30.77% | 26.37% | 2.59% | 0.00% | -111.90% | ||
| Net Profit | 0.00 | 0.00 | 0.01 | 0.02 | 0.17 | 0.60 | 0.09 | 0.18 | 1.49 | 1.13 | -8.83 | 0.88 |
| EPS in Rs | 0.00 | 0.00 | 0.01 | 0.02 | 0.17 | 0.60 | 0.01 | 0.01 | 0.10 | 0.06 | -0.48 | 0.05 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 100.00% | 750.00% | 252.94% | -85.00% | 100.00% | 727.78% | -24.16% | -881.42% | 109.97% |
| Change in YoY Net Profit Growth (%) | 0.00% | 650.00% | -497.06% | -337.94% | 185.00% | 627.78% | -751.94% | -857.25% | 991.38% |
Vaxtex Cotfab Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2016-2017 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -28% |
| 3 Years: | -56% |
| TTM: | -9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 58% |
| 3 Years: | -16% |
| TTM: | 111% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | -17% |
| 3 Years: | -53% |
| 1 Year: | 49% |
| Return on Equity | |
|---|---|
| 10 Years: | -3% |
| 5 Years: | -5% |
| 3 Years: | -10% |
| Last Year: | 5% |
Last Updated: September 5, 2025, 1:51 pm
Balance Sheet
Last Updated: September 10, 2025, 2:47 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.40 | 0.40 | 0.40 | 0.40 | 0.40 | 0.40 | 6.02 | 6.02 | 10.04 | 12.63 | 18.38 | 18.38 |
| Reserves | 3.53 | 3.53 | 3.53 | 3.55 | 3.72 | 4.33 | 2.63 | 2.85 | 0.32 | 10.85 | 0.42 | -0.04 |
| Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.25 | 3.29 | 12.62 | 10.30 | 7.45 | 5.20 | 11.51 | 11.13 |
| Other Liabilities | 0.03 | 0.00 | 0.27 | 0.75 | 5.82 | 5.49 | 6.65 | 2.52 | 6.18 | 40.80 | 18.56 | 19.00 |
| Total Liabilities | 3.96 | 3.93 | 4.20 | 4.70 | 10.19 | 13.51 | 27.92 | 21.69 | 23.99 | 69.48 | 48.87 | 48.47 |
| Fixed Assets | 0.00 | 0.00 | 0.00 | 0.36 | 1.70 | 1.80 | 2.37 | 3.85 | 3.90 | 3.65 | 1.14 | 1.04 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.89 | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.12 | 0.08 | 1.05 | 1.10 | 7.01 | 7.54 |
| Other Assets | 3.07 | 3.88 | 4.20 | 4.34 | 8.49 | 11.71 | 25.43 | 17.76 | 19.04 | 64.73 | 40.72 | 39.89 |
| Total Assets | 3.96 | 3.93 | 4.20 | 4.70 | 10.19 | 13.51 | 27.92 | 21.69 | 23.99 | 69.48 | 48.87 | 48.47 |
Below is a detailed analysis of the balance sheet data for Vaxtex Cotfab Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 18.38 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 18.38 Cr..
- For Reserves, as of Mar 2025, the value is -0.04 Cr.. The value appears to be declining and may need further review. It has decreased from 0.42 Cr. (Mar 2024) to -0.04 Cr., marking a decrease of 0.46 Cr..
- For Borrowings, as of Mar 2025, the value is 11.13 Cr.. The value appears to be improving (decreasing). However, Reserves are negative, which is a major warning sign. It has decreased from 11.51 Cr. (Mar 2024) to 11.13 Cr., marking a decrease of 0.38 Cr..
- For Other Liabilities, as of Mar 2025, the value is 19.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 18.56 Cr. (Mar 2024) to 19.00 Cr., marking an increase of 0.44 Cr..
- For Total Liabilities, as of Mar 2025, the value is 48.47 Cr.. The value appears to be improving (decreasing). It has decreased from 48.87 Cr. (Mar 2024) to 48.47 Cr., marking a decrease of 0.40 Cr..
- For Fixed Assets, as of Mar 2025, the value is 1.04 Cr.. The value appears to be declining and may need further review. It has decreased from 1.14 Cr. (Mar 2024) to 1.04 Cr., marking a decrease of 0.10 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 7.54 Cr.. The value appears strong and on an upward trend. It has increased from 7.01 Cr. (Mar 2024) to 7.54 Cr., marking an increase of 0.53 Cr..
- For Other Assets, as of Mar 2025, the value is 39.89 Cr.. The value appears to be declining and may need further review. It has decreased from 40.72 Cr. (Mar 2024) to 39.89 Cr., marking a decrease of 0.83 Cr..
- For Total Assets, as of Mar 2025, the value is 48.47 Cr.. The value appears to be declining and may need further review. It has decreased from 48.87 Cr. (Mar 2024) to 48.47 Cr., marking a decrease of 0.40 Cr..
However, the Borrowings (11.13 Cr.) are higher than the Reserves (-0.04 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 0.00 | -0.01 | -0.02 | 0.02 | 0.12 | -2.35 | -11.25 | -8.86 | -4.44 | -5.35 | -18.00 | -11.63 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
No data available for the Financial Efficiency data table.
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 2.00 | 10.00 |
| Basic EPS (Rs.) | 0.05 | -0.59 | 0.11 | 0.30 | 0.30 |
| Diluted EPS (Rs.) | 0.05 | -0.59 | 0.11 | 0.30 | 0.30 |
| Cash EPS (Rs.) | 0.05 | -0.47 | 0.11 | 0.35 | 0.54 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 0.99 | 1.02 | 1.86 | 2.06 | 14.73 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 0.99 | 1.02 | 1.86 | 2.06 | 14.73 |
| Revenue From Operations / Share (Rs.) | 0.28 | 0.90 | 5.99 | 12.33 | 43.42 |
| PBDIT / Share (Rs.) | 0.03 | -0.46 | 0.04 | 0.67 | 2.49 |
| PBIT / Share (Rs.) | 0.02 | -0.47 | 0.01 | 0.61 | 2.24 |
| PBT / Share (Rs.) | 0.02 | -0.48 | 0.09 | 0.40 | 0.43 |
| Net Profit / Share (Rs.) | 0.04 | -0.48 | 0.08 | 0.29 | 0.29 |
| PBDIT Margin (%) | 11.96 | -51.83 | 0.67 | 5.46 | 5.72 |
| PBIT Margin (%) | 9.97 | -52.75 | 0.30 | 4.98 | 5.15 |
| PBT Margin (%) | 7.83 | -53.15 | 1.53 | 3.24 | 1.00 |
| Net Profit Margin (%) | 16.81 | -53.15 | 1.49 | 2.39 | 0.68 |
| Return on Networth / Equity (%) | 4.81 | -47.01 | 4.82 | 14.34 | 2.00 |
| Return on Capital Employeed (%) | 2.03 | -30.18 | 0.80 | 18.53 | 7.04 |
| Return On Assets (%) | 1.82 | -18.07 | 1.62 | 6.19 | 0.82 |
| Long Term Debt / Equity (X) | 0.40 | 0.53 | 0.22 | 0.58 | 1.14 |
| Total Debt / Equity (X) | 0.60 | 0.61 | 0.22 | 0.71 | 1.16 |
| Asset Turnover Ratio (%) | 0.10 | 0.28 | 1.62 | 2.71 | 1.05 |
| Current Ratio (X) | 1.80 | 2.11 | 1.62 | 2.72 | 5.11 |
| Quick Ratio (X) | 1.80 | 2.10 | 1.59 | 1.99 | 4.44 |
| Inventory Turnover Ratio (X) | 0.00 | 26.64 | 19.63 | 16.24 | 7.54 |
| Interest Coverage Ratio (X) | 5.58 | -130.94 | 0.81 | 3.15 | 1.38 |
| Interest Coverage Ratio (Post Tax) (X) | 8.85 | -133.26 | 0.32 | 2.38 | 1.16 |
| Enterprise Value (Cr.) | 23.07 | 28.95 | 32.88 | 125.26 | 36.65 |
| EV / Net Operating Revenue (X) | 4.39 | 1.74 | 0.43 | 2.02 | 1.40 |
| EV / EBITDA (X) | 36.72 | -3.36 | 64.30 | 37.03 | 24.46 |
| MarketCap / Net Operating Revenue (X) | 2.27 | 1.05 | 0.36 | 1.91 | 1.01 |
| Price / BV (X) | 0.65 | 0.92 | 1.18 | 11.39 | 2.98 |
| Price / Net Operating Revenue (X) | 2.27 | 1.05 | 0.36 | 1.91 | 1.01 |
| EarningsYield | 0.07 | -0.50 | 0.04 | 0.01 | 0.01 |
After reviewing the key financial ratios for Vaxtex Cotfab Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from -0.59 (Mar 24) to 0.05, marking an increase of 0.64.
- For Diluted EPS (Rs.), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from -0.59 (Mar 24) to 0.05, marking an increase of 0.64.
- For Cash EPS (Rs.), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 3. It has increased from -0.47 (Mar 24) to 0.05, marking an increase of 0.52.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 0.99. It has decreased from 1.02 (Mar 24) to 0.99, marking a decrease of 0.03.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 0.99. It has decreased from 1.02 (Mar 24) to 0.99, marking a decrease of 0.03.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 0.28. It has decreased from 0.90 (Mar 24) to 0.28, marking a decrease of 0.62.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 0.03. This value is below the healthy minimum of 2. It has increased from -0.46 (Mar 24) to 0.03, marking an increase of 0.49.
- For PBIT / Share (Rs.), as of Mar 25, the value is 0.02. This value is within the healthy range. It has increased from -0.47 (Mar 24) to 0.02, marking an increase of 0.49.
- For PBT / Share (Rs.), as of Mar 25, the value is 0.02. This value is within the healthy range. It has increased from -0.48 (Mar 24) to 0.02, marking an increase of 0.50.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.04. This value is below the healthy minimum of 2. It has increased from -0.48 (Mar 24) to 0.04, marking an increase of 0.52.
- For PBDIT Margin (%), as of Mar 25, the value is 11.96. This value is within the healthy range. It has increased from -51.83 (Mar 24) to 11.96, marking an increase of 63.79.
- For PBIT Margin (%), as of Mar 25, the value is 9.97. This value is below the healthy minimum of 10. It has increased from -52.75 (Mar 24) to 9.97, marking an increase of 62.72.
- For PBT Margin (%), as of Mar 25, the value is 7.83. This value is below the healthy minimum of 10. It has increased from -53.15 (Mar 24) to 7.83, marking an increase of 60.98.
- For Net Profit Margin (%), as of Mar 25, the value is 16.81. This value exceeds the healthy maximum of 10. It has increased from -53.15 (Mar 24) to 16.81, marking an increase of 69.96.
- For Return on Networth / Equity (%), as of Mar 25, the value is 4.81. This value is below the healthy minimum of 15. It has increased from -47.01 (Mar 24) to 4.81, marking an increase of 51.82.
- For Return on Capital Employeed (%), as of Mar 25, the value is 2.03. This value is below the healthy minimum of 10. It has increased from -30.18 (Mar 24) to 2.03, marking an increase of 32.21.
- For Return On Assets (%), as of Mar 25, the value is 1.82. This value is below the healthy minimum of 5. It has increased from -18.07 (Mar 24) to 1.82, marking an increase of 19.89.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.40. This value is within the healthy range. It has decreased from 0.53 (Mar 24) to 0.40, marking a decrease of 0.13.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.60. This value is within the healthy range. It has decreased from 0.61 (Mar 24) to 0.60, marking a decrease of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.10. It has decreased from 0.28 (Mar 24) to 0.10, marking a decrease of 0.18.
- For Current Ratio (X), as of Mar 25, the value is 1.80. This value is within the healthy range. It has decreased from 2.11 (Mar 24) to 1.80, marking a decrease of 0.31.
- For Quick Ratio (X), as of Mar 25, the value is 1.80. This value is within the healthy range. It has decreased from 2.10 (Mar 24) to 1.80, marking a decrease of 0.30.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 4. It has decreased from 26.64 (Mar 24) to 0.00, marking a decrease of 26.64.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 5.58. This value is within the healthy range. It has increased from -130.94 (Mar 24) to 5.58, marking an increase of 136.52.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 8.85. This value is within the healthy range. It has increased from -133.26 (Mar 24) to 8.85, marking an increase of 142.11.
- For Enterprise Value (Cr.), as of Mar 25, the value is 23.07. It has decreased from 28.95 (Mar 24) to 23.07, marking a decrease of 5.88.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.39. This value exceeds the healthy maximum of 3. It has increased from 1.74 (Mar 24) to 4.39, marking an increase of 2.65.
- For EV / EBITDA (X), as of Mar 25, the value is 36.72. This value exceeds the healthy maximum of 15. It has increased from -3.36 (Mar 24) to 36.72, marking an increase of 40.08.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.27. This value is within the healthy range. It has increased from 1.05 (Mar 24) to 2.27, marking an increase of 1.22.
- For Price / BV (X), as of Mar 25, the value is 0.65. This value is below the healthy minimum of 1. It has decreased from 0.92 (Mar 24) to 0.65, marking a decrease of 0.27.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.27. This value is within the healthy range. It has increased from 1.05 (Mar 24) to 2.27, marking an increase of 1.22.
- For EarningsYield, as of Mar 25, the value is 0.07. This value is below the healthy minimum of 5. It has increased from -0.50 (Mar 24) to 0.07, marking an increase of 0.57.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Vaxtex Cotfab Ltd:
- Net Profit Margin: 16.81%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 2.03% (Industry Average ROCE: 11.98%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 4.81% (Industry Average ROE: 23.09%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 8.85
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.8
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 18.9 (Industry average Stock P/E: 344.46)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.6
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 16.81%
About the Company - Qualitative Analysis
Vaxtex Cotfab Ltd. is a Public Limited Listed company incorporated on 26/12/2005 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L51109GJ2005PLC076930 and registration number is 076930. Currently Company is involved in the business activities of Preparation and spinning of jute, mesta and other natural fibers including blended natural fibers *blended yarn/fabrics means, yarn/fabrics containing more than 50% of one fiber.. Company's Total Operating Revenue is Rs. 5.25 Cr. and Equity Capital is Rs. 18.38 Cr. for the Year ended 31/03/2025.
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Textiles - General | J-03 (GF to 4th Floor) Tejendra Arcade, Nr, Ganjifarak Mill Compound, Ahmedabad Gujarat 380023 | vaxtexcotfab@gmail.com www.vaxtexcotfabltd.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Aakash Rajeshbhai Thakor | Managing Director |
| Mr. Devi Singh | Non Executive Director |
| Mr. Pranav Vajani | Independent Director |
| Mr. Ravi Jitendra Modi | Independent Director |
| Mr. Harsh Mahendrakumar Kothari | Independent Director |
| Ms. Hardika Ladha | Independent Director |
FAQ
What is the intrinsic value of Vaxtex Cotfab Ltd?
Vaxtex Cotfab Ltd's intrinsic value (as of 17 September 2025) is 0.73 which is 31.13% lower the current market price of 1.06, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹19.5 Cr. market cap, FY2025-2026 high/low of 1.31/0.60, reserves of ₹-0.04 Cr, and liabilities of 48.47 Cr.
What is the Market Cap of Vaxtex Cotfab Ltd?
The Market Cap of Vaxtex Cotfab Ltd is 19.5 Cr..
What is the current Stock Price of Vaxtex Cotfab Ltd as on 17 September 2025?
The current stock price of Vaxtex Cotfab Ltd as on 17 September 2025 is 1.06.
What is the High / Low of Vaxtex Cotfab Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Vaxtex Cotfab Ltd stocks is 1.31/0.60.
What is the Stock P/E of Vaxtex Cotfab Ltd?
The Stock P/E of Vaxtex Cotfab Ltd is 18.9.
What is the Book Value of Vaxtex Cotfab Ltd?
The Book Value of Vaxtex Cotfab Ltd is 1.00.
What is the Dividend Yield of Vaxtex Cotfab Ltd?
The Dividend Yield of Vaxtex Cotfab Ltd is 0.00 %.
What is the ROCE of Vaxtex Cotfab Ltd?
The ROCE of Vaxtex Cotfab Ltd is 1.77 %.
What is the ROE of Vaxtex Cotfab Ltd?
The ROE of Vaxtex Cotfab Ltd is 4.74 %.
What is the Face Value of Vaxtex Cotfab Ltd?
The Face Value of Vaxtex Cotfab Ltd is 1.00.